EDTUTC-4 New YorkLog in Sign up

PPCB
Propanc Biopharma, Inc. Common Stock
stockNASDAQ

Market OpenOct 12, 2026 12:03:31 PM EDT

0.43USD-11.468%(-0.06)175,917

0.4000Bid0.5500Ask0.1500Spread

Pre-marketOct 12, 2026 9:27:30 AM EDT

0.4695USD-3.335%(-0.0162)

PPCB News

Day breaks

08:30 AM EDTPropanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib ·

GlobeNewswire Inc.

11:25 AM EDTPropanc Biopharma, Inc. GAAP EPS of -$17.62 ·

Seeking Alpha

08:44 AM EDTPropanc Biopharma reports $18.9M loss, plans phase 1b trial ·

Investing.com

08:30 AM EDTPropanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results ·

GlobeNewswire Inc.

08:30 AM EDTPropanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015 ·

GlobeNewswire Inc.

08:30 AM EDTPropanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc. ·

GlobeNewswire Inc.